Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
BiomeBank Plans to Open a New State-of-the-Art GMP Facility in Adelaide, Australia
BiomeBank plans to open a new good manufacturing practise GMP facility to advance biomedical research and production in Adelaide, Australia
FUJIFILM Diosynth Biotechnologies Unveils US$200 million to Open New Manufcaturing Capacity in USA
FUJIFILM Diosynth Biotechnologies invests US$200 million to open new facility to expand cell therapy capabilities in USA
Full-Life Technologies Commences Construction on State-of-the-Art GMP Manufacturing Facility in Belgium, Europe
FullLife Technologies breaks ground for GMP manufacturing facility to advance its endtoend solution for radiopharmaceuticals in Belgium, Europe
Merck Invests US$31 million (€29 million) to Complete Biologics Testing Centre in Shanghai, China
Merck with an investment of US$31 million 29 million has completed the construction of new biologics testing centre in Shanghai, China
Eli Lilly Invests US$2.5 billion to Expand Injectable Manufacturing Capacity in Alzey, Germany
Eli Lilly plans to build a new US$25 billion cuttingedge manufacturing site in Alzey, Germany
Indiana University Invests US$250 million to Open Life Sciences Campus in Indianapolis, USA
Indiana University plans to invest US$250 million to open a new campus to advance scientific discoveries aimed at curing and treating diseases and improving human health
Bayer Invests US$250 million to Open New Cell Therapy Manufacturing Facility in USA
Bayer plans to open new cell therapy manufacturing facility with an investment of US$250 million The facility will be loacted in California, USA
The Keck School of Medicine of USC Plans to Open Cell Therapy Manufacturing Facility in USA
The Keck School of Medicine of USC plans to open new cell therapy manufacturing facility The facility will be located in USA
Novo Nordisk Unveils Plans to Expand US$6 billion (INR 507 billion) Manufacturing Facilities in Denmark, Europe
Novo Nordisk invests US$6 biilion INR 507 billion to expand its existing manufacturing facilities in Denmark, Europe
FUJIFILM Diosynth Biotechnologies Invests US$2 billion to Construct New Manufacturing Facility in North California, USA
FUJIFILM Diosynth Biotechnologies is investing US$2 billion to open new largescale cell culture manufacturing facility in North Carolina, USA
